What’s New October 2021

Published on 10/27/2021

4 min read

Newsletter updates for October 2021
*|MC:SUBJECT|*

alt_text

Newsletter – October 2021

SOPHiA Clinical Exome Solution v3 offers a streamlined end-to-end workflow to facilitate the assessment of challenging Mendelian disorders

SOPHiA Clinical Exome Solution v3 combines a capture-based target enrichment kit with the analytical capabilities and interpretation-support functionalities of the SOPHiA DDM™ platform…

Staying a step ahead of breast cancer with data-driven medicine

A comprehensive test for detecting mutations on BRCA1/2 and other well-known genes linked to breast cancer is crucial and will determine risk level. 

What is the SOPHiA DDM™ universal platform?

 
Think of it like trying to find a treasure buried on a beach. It would be a lot easier to use a metal detector than to pick through each grain of sand. Read more in our new blog…

NGS cancer research in the time of COVID-19

The medical research community has been buried in data since well before the global COVID-19 pandemic. How they’re now managing the extreme additional influx of SARS-CoV-2 data determines the outcomes of a lab’s overall research capabilities.

Upcoming events


LACAM, la historia de éxito de un Consorcio Genómico en Latinoamérica
November 18, 2021
WEBINAR


RSNA 2021
November 28, 2021 – December 2, 2021
IN-PERSON


arrow arrow arrow arrow arrow

DISCLAIMER

The information included in this document has been prepared for and is intended for viewing by a global audience. This document contains information about products and services which may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indication for use. Please consult local sales representative.

 

alt_text

Related Posts

pink dots icon

Want to know more?
Get in touch with us.

Our client services team is on hand to help.